Spelling suggestions: "subject:"bonemarrow"" "subject:"marrow""
831 |
Molecular and phenotypic studies of human antigen-specific effector- and memory B cellsGiesecke, Claudia 18 December 2015 (has links)
Gedächtnis-B-Zellen und Plasmazellen sind essentielle Komponenten der protektiven Immunität. Die Mechanismen ihrer Induktion, ihres Überlebens und der Gedächtnis-B-Zellreaktivierung sind allerding bisher nur unvollständig verstanden. Um unser Wissen diesbezüglich zu erweitern, wurden in der vorliegenden Arbeit zum einen Charakteristika von Primär- und Sekundärimmunantworten nach Immunisierung mit Keyhole Limpet Hemocyanin (KLH) untersucht und zum anderen das Vorkommen sowie der Phänotyp humaner Gedächtnis-B-Zellen in verschiedenen lymphatischen Geweben analysiert. Die primäre parenterale KLH Immunisierung führte auf serologischer und zellulärer Ebene zu einer Reihe unerwarteter Ergebnisse, welche u. a. das Auftreten von IgA Antikörpern und die gleichzeitige Präsenz von hoch- und wenig mutierten primären Plasmablasten beinhalteten. Die Untersuchung der Gedächtnis-B-Zellverteilung in verschiedenen lymphatischen Geweben ergab den größten Gedächtnis-B-Zellpool in der Milz. Blut-, Tonsillen-, Knochenmarks- und Milz-Gedächtnis-B-Zellen wiesen nur wenige phänotypische Unterschiede auf. Einer davon war die CD69 Expression auf tonsillären ruhenden Gedächtnis-B-Zellen, was darauf hindeutet, dass tonsilläre Gedächtnis-B-Zellen tatsächlich sessil sein könnten. Die hier erhaltenen Ergebnisse stellen neue Erkenntnisse über bisher unbeschriebene Mechanismen bei parenteralen Immunantworten wie zum Beispiel die Induktion von IgA Antikörpern sowie die potentielle Rekrutierung kreuzreaktiver Gedächtnis-B-Zellen dar. Es bleibt zu klären, wie die Reaktivierung solcher Gedächtnis-B-Zellen reguliert ist. Derartiges Wissen wäre insbesondere für Therapien von Erkrankungen des Immunsystems, wie Autoimmunität, von Bedeutung. Das potentiell patrouillierende Verhalten der Gedächtnis-B-Zellen ist ein markanter Unterschied zu den nischenabhängigen sessilen Plasmazellen und deutet weitestgehend darauf hin, dass Gedächtnis-B-Zellen nicht auf derartige Nischen angewiesen sind. / Memory B cells (mBC) and antibodies are major mediators of protective immune responses yet the mechanisms of their induction, maintenance and mBC reactivation are poorly understood. Therefore, to enhance knowledge in this regard this study comprehensively characterized a human primary and secondary B cell immune response to Keyhole Limpet Hemocyanin (KLH). Secondly, mBC maintenance was investigated by a systematic analysis of mBC presence, frequency and phenotype within different lymphoid organs. Parenteral primary KLH immunization yielded unexpected results on the serological and B cellular level, including KLH-specific IgA antibody induction, the simultaneous presence of low and highly mutated circulating KLH-specific primary plasmablasts and only little clonal overlap between the primary, memory and secondary KLH-specific B cell repertoires. With respect to the organ distribution of human mBC, the spleen was identified as a major mBC reservoir. Splenic, tonsillar, bone marrow and blood mBC pools exhibited a largely comparable phenotype. Yet, we found tonsillar mBC to express CD69. Due to their resting state tonsillar mBC could therefore constitute a tissue resident cell population. The observations described allow insights into hitherto unknown potential mechanisms behind primary immune responses, i.e. prominent IgA induction by parenteral challenge and inclusion of cross-reactive mBC. The so far unclear regulatory players involved deserve future investigation, as such knowledge may be crucial for therapeutic interventions in immune system disorders. Furthermore, strikingly different to the resident plasma cells in the bone marrow, mBC appear to distribute between lymphoid organs and continuously recirculate in peripheral blood indicative of their potential permanent screening activities, suggesting that human mBC do not require one dedicated niche for their principle survival.
|
832 |
Charakterisierung von Plasmazellsubpopulationen im humanen KnochenmarkKruck, Ina 09 November 2015 (has links)
Plasmazellen gehören zu den Effektorzellen des adaptiven Immunsystems. Langlebige Plasmazellen tragen durch kontinuierliche Sekretion protektiver Antikörper wesentlich zum humoralen Gedächtnis bei und überleben hauptsächlich in spezialisierten Nischen des Knochenmarks. Bislang ist jedoch kein Marker bekannt, mit dessen Hilfe langlebige Plasmazellen eindeutig identifiziert werden können. Die vorliegende Arbeit befasst sich mit der molekularbiologischen, phänotypischen und funktionellen Charakterisierung von reifen Plasmazellen im gesunden humanen Knochenmark, die sich durch die differentielle Expression von CD19 unterscheiden. Dabei konnte festgestellt werden, dass CD19negative Plasmazellen durch eine vergleichsweise geringere Expression von CD45 und HLADR einen höheren Reifegrad aufweisen als CD19positive Plasmazellen. Zudem lässt die vermehrte Expression von CD28, Mcl1, Bcl2 sowie die schwächere Expression u.a. von CD95 darauf schließen, dass CD19negative Plasmazellen im Knochenmark eine bessere Überlebenskapazität besitzen als CD19positive Plasmazellen. Da beide Plasmazellpopulationen ähnliche Antigen-Spezifitäten aufweisen, Plasmazellen im Knochenmark von Säuglingen ausschließlich CD19 exprimieren und nach sekundärer Vakzinierung im Blut detektierbare Plasmablasten und Plasmazellen ebenfalls CD19 auf ihrer Oberfläche exprimieren, weist die Gesamtheit der Daten darauf hin, dass sich CD19negative Plasmazellen im Kindesalter in situ aus reifen CD19positiven Plasmazellen im Knochenmark entwickeln. Die CD19negative Plasmazellpopulation leistet durch hohe Halbwertszeit und Stabilität einen konstanten Beitrag zur Aufrechterhaltung des humoralen Gedächtnisses. Die CD19positive Plasmazellpopulation stellt hingegen eine flexible Komponente dar, die eine Anpassung der humoralen Immunität und des humoralen Gedächtnisses an aktuelle Herausforderungen auch im Erwachsenenalter ermöglicht. / Plasma cells are effector cells of the adaptive immune system. Humoral memory is sustained by long-lived plasma cells that continuously secrete protective antibodies and mostly reside in specialized niches in the bone marrow. So far, no marker is known that could distinguish long-lived plasma cells from short-lived ones. The present work addresses the biomolecular, phenotypical and functional characterization of mature plasma cells in healthy human bone marrow that differ in their expression of the surface marker CD19. CD19negative plasma cells showed higher maturity than CD19positive plasma cells as they expressed lesser amounts of CD45 and HLADR. Moreover, higher expression of CD28, Mcl1 and Bcl2 and lesser expression of CD95 argues for a better survival capacity of CD19negative plasma cells. Both plasma cell populations showed similar antigen specificities. All plasmablasts and plasma cells detectable in blood after secondary vaccination expressed CD19, as well as all plasma cells isolated from infant bone marrow. These results indicate that CD19negative plasma cells mainly develop during childhood by further differentiation of mature CD19positive plasma cells in situ in the bone marrow. CD19negative plasma cells represent a long-lived and stable component of the adaptive immune system and humoral memory, whereas the CD19positive plasma cell population displays a flexible element allowing for adaption of humoral immunity to new challenges throughout a lifetime.
|
833 |
Avaliação da reconstituição imunológica e da resposta anti-citomegalovirus nos receptores de transplante de medula óssea / Anti-cytomegalovirus immunity reconstitution following autologous and allogeneic stem cell and bone marrow transplantation as assessed by CD8+ T cell phenotyping and functioFerrari, Valeria 23 February 2005 (has links)
O citomegalovírus (CMV) é uma séria ameaça aos receptores de transplante de medula óssea. A reativação está associada com uma imunidade mediada por células TCD8+ defeituosa. Nosso objetivo foi correlacionar as diferentes subpopulações de células TCD8+ com a reconstituição imunológica dos pacientes, especificamente a imunidade anti-CMV, analisando as subpopulações de células T infundidas nas diferentes modalidades de transplante de medula óssea. Receptores de transplante alogênico de células tronco mobilizadas para o sangue periférico (n=16) ou coletadas diretamente da medula óssea (n=28) e receptores de transplante autólogo de células tronco mobilizadas para o sangue periférico (n=22) foram avaliados. Verificamos que as transferências de células mobilizadas para o sangue periférico dos doadores, tanto nos transplantes alogênicos como autólogos, são proporcionalmente enriquecidas por subpopulações de células memória efetora e efetora, comparadas às transferências de células procedentes diretamente da medula óssea. Este enriquecimento por subpopulações de células TCD8+ mais diferenciadas foi também correlacionado com maior número de células contendo altos níveis de granzima B, considerado um marcador para linfócitos citotóxicos, sendo também encontrado em maior número nas transferências de células do sangue periférico. Entretanto, no pós-transplante, observou-se que somente os receptores de transplante autólogo de células tronco mobilizadas para o sangue periférico, e não os das outras modalidades de transplante, exibiam números elevados de células T CD8+ de memória-efetora e efetora. Ao mesmo tempo, estes receptores apresentaram menos freqüentemente episódios de reativação pelo CMV, e mais freqüentemente produziram IFN-gama em resposta ao CMV. Portanto, a transferência de células do sangue periférico, desde que em ambiente autólogo, está associada não só com a transferência de células TCD8+ com um fenótipo mais maduro, mas também com uma persistência mais prolongada das mesmas, podendo proporcionar uma resposta imunológica antiviral mais rápida e eficiente, como esperado para as células de memória versus naïve. / Cytomegalovirus (CMV) is a serious threat to the recipients of bone marrow transplantation. Reactivation is associated with defective CD8+ T cell-mediated immunity. We aimed to correlate the different subsets of CD8+ T cells with the patients\' immune reconstitution, specifically anti CMV immunity, by analyzing the CD8+ T cell subsets infused in the different types of bone marrow transplantation. Recipients of allogeneic transplant of peripheral blood stem cells (n=16) or bone marrow (n=28) and recipients of autologous transplant of peripheral blood stem cells (n=22) were evaluated. We show that infusions of stem cells derived from donor\'s peripheral blood, either allogeneic or autologous, are proportionally enriched for the memory-effector and effector phenotypes, compared to the infusions of stem cells of bone marrow origin. This increased number of more differentiated subsets of CD8+ T cells was also correlated with an increased number of cells containing high levels of granzyme B, which is another reliable marker of cytotoxic lymphocyte, and which was also more evident in autologous recipients. However, post-transplant, we observed that only the recipients of autologous peripheral blood cells, and not the recipients of the other transplant modalities, exhibited very high numbers of memory-effector and effector TCD8+ cells. At the same time, they less frequently presented CMV reactivation, and more frequently produced IFN-gama in response to CMV antigens. Thus, transfer of stem cells from peripheral blood, provided in an autologous setting, is associated with transfer and prolonged survival of CD8+ T cells with a more mature phenotype, which may provide a more rapid and efficient anti-viral immune response, as expected for memory versus naïve cells.
|
834 |
Diagnóstico de vírus por microscopia eletrônica em urina de pacientes com hematúrias/cistite hemorrágica após transplante de medula óssea: associação com aspectos clínicos / Electron microscopic viral diagnosis in urine of patients with hematuria/hemorrhagic cystitis after bone marrow transplantation: association with clinical aspectsJussara Bianchi Castelli 12 December 2000 (has links)
Pacientes submetidos ao transplante de medula óssea, apresentando hematúria/cistite hemorrágica, tiveram amostras de urina analisadas pela microscopia eletrônica. Esta foi a técnica escolhida de pesquisa viral pela sua confiabilidade. Noventa em 402 pacientes submetidos ao transplante de medula óssea neste serviço apresentaram hematúria/cistite hemorrágica (incidência de 22%). O estudo por microscopia eletrônica foi realizado em 72 destes pacientes com hematúria/cistite hemorrágica (grupo de estudo), identificando 55,6% (40/72) de positividade viral. Foram também estudadas amostras de urina de 12 pacientes submetidos ao transplante de medula óssea sem hematúria/cistite hemorrágica (grupo controle); houve associação significante entre a presença de vírus e hematúria/cistite hemorrágica (p<0,01 - Teste exato de Fisher). No grupo com hematúria/cistite hemorrágica, 65% (26/40) dos vírus detectados pertenciam à família Poliomaviridae, 30% (12/40) à Adenoviridae, e 5% (2/40) foram positivos para ambas as famílias. Houve associação entre a positividade para vírus e a presença da doença enxerto-contra-hospedeiro (p=0,05-x2) e o de início tardio (>dia+21) da H/CH (P=0,04-x2), bem como entre a doença enxerto-contra-hospedeiro e a severidade da H/CH (p=0,04-x2). O presente estudo mostra que a microscopia eletrônica é uma ferramenta útil para detecção de vírus na urina de pacientes submetidos ao transplante de medula óssea apresentando hematúria/cistite hemorrágica e que o vírus provavelmente tem um papel no desenvolvimento do sangramento urinário, o qual é agravado pelo doença enxerto-contra-hospedeiro. A microscopia eletrônica deveria ser realizada rotineiramente para guiar as outras técnicas de detecção viral, como a imunocitoquímica e biologia molecular. / Patients submitted to bone marrow transplantation presenting hematuria/hemorrhagic cystitis had the urine analyzed by electron microscopy. It was the elected technique for viral search because its reliability. Ninety from 402 patients submitted to bone marrow transplantation at this service showed hematuria/hemorrhagic cystitis (incidence of 22%). Electron microscopy study was performed in 72 of these patients with hematuria/hemorrhagic cystitis (study group), identifying 55.5% (40/72) of viral positivity. It was also study the urine of 12 patients submitted to bone marrow transplantation without hematuria/hemorrhagic cystitis (control group); there was a significant association between the presence of virus and hematuria/hemorrhagic cystitis (p<0.01). In the hematuria/hemorrhagic cystitis group, 65% (26/40) of the virus belonged to Poliomaviridae family, 30% (12/40) to Adenoviridae, and 5% (2/40) to both families. There was association between the status of graft-versus-host disease and positivity for virus (p=0.05), as well as between graft-versus-host disease and the severity of hematuria/hemorrhagic cystitis (p=0.04). The present study shows that electron microscopy is a useful tool for detection of virus in urine of patients submitted to bone marrow transplantation presenting hematuria/hemorrhagic cystitis and that the virus probably play a role in the development of the urinary bleeding, which is aggravated by graft-versus-host disease. Electron microscopy should be performed routinely to guide the other techniques for viral detection, like immunocitochemistry and molecular biology.
|
835 |
Untersuchungen zur Rekrutierung myeloischer Zellen in einem Tiermodell der Alzheimerschen Erkrankung / Analysis of myeloid cell recruitment in an animal model of Alzheimer s DiseaseSchlevogt, Bernhard Martin 15 February 2012 (has links)
No description available.
|
836 |
Défaillance cardiaque et mécanismes de protection et réparation du myocardeMaltais, Simon 08 1900 (has links)
La cardiomyopathie ischémique et l’insuffisance cardiaque (IC) sont deux des principales causes de morbidité et de mortalité dans les pays industrialisés. L’IC représente la condition finale résultant de plusieurs pathologies affectant le myocarde. Au Canada, plus de 400 000 personnes souffrent d’IC. Malgré la grande variété de traitements disponibles pour prendre en charge ces patients à haut risque de mortalité, l’évolution et le pronostic clinique de cette population demeurent sombres. Les thérapies de régénération par transplantation cellulaire représentent de nouvelles approches pour traiter les patients souffrant d’IC. L’impact de cette approche cellulaire et les mécanismes qui sous-tendent l’application de ce nouveau mode de traitement demeurent obscurs. Les hypothèses proposées dans cette thèse sont les suivantes : 1) l’évolution à long terme des patients qui se présentent en IC grave est nettement défavorable malgré les techniques actuelles de revascularisation chirurgicale à cœur battant; 2) la thérapie cellulaire et, plus spécifiquement, l’injection intracoronaire précoce de milieu de culture cellulaire, permet d’améliorer la récupération fonctionnelle du ventricule gauche suite à un infarctus aigu du myocarde; et 3) la mobilisation de l’axe cœur-moelle osseuse constitue un mécanisme de réponse important lors de la survenue d’un événement ischémique chronique affectant le myocarde. / Congestive heart failure (CHF) remains a leading cause of mortality in the developed world. There are more than 400,000 diagnosed cases of this pathology in Canada. Despite the numerous treatment options available for patients presenting with left ventricular dysfunction, the evolution of this population is still dismal. Stem cell transplantation is a potential approach to repopulate the injured myocardium, to treat heart failure, and to restore cardiac function. However, the exact mechanisms underlying the beneficial effects of this approach remain to be elucidated. The hypotheses of this thesis are the following: 1) the long-term evolution of patients undergoing coronary artery bypass graft surgery is still poor, even when considering the use of new innovative surgical strategies such as off-pump coronary revascularization; 2) the intracoronary injection of concentrated biologically active factors secreted by stem cells can achieve early protection of the ischemic myocardium and preserve heart function; and 3) the bone marrow/heart interaction in a critical axis is involved in chronic myocardial repair following persistent ischemic injury.
|
837 |
Avaliação da reconstituição imunológica e da resposta anti-citomegalovirus nos receptores de transplante de medula óssea / Anti-cytomegalovirus immunity reconstitution following autologous and allogeneic stem cell and bone marrow transplantation as assessed by CD8+ T cell phenotyping and functioValeria Ferrari 23 February 2005 (has links)
O citomegalovírus (CMV) é uma séria ameaça aos receptores de transplante de medula óssea. A reativação está associada com uma imunidade mediada por células TCD8+ defeituosa. Nosso objetivo foi correlacionar as diferentes subpopulações de células TCD8+ com a reconstituição imunológica dos pacientes, especificamente a imunidade anti-CMV, analisando as subpopulações de células T infundidas nas diferentes modalidades de transplante de medula óssea. Receptores de transplante alogênico de células tronco mobilizadas para o sangue periférico (n=16) ou coletadas diretamente da medula óssea (n=28) e receptores de transplante autólogo de células tronco mobilizadas para o sangue periférico (n=22) foram avaliados. Verificamos que as transferências de células mobilizadas para o sangue periférico dos doadores, tanto nos transplantes alogênicos como autólogos, são proporcionalmente enriquecidas por subpopulações de células memória efetora e efetora, comparadas às transferências de células procedentes diretamente da medula óssea. Este enriquecimento por subpopulações de células TCD8+ mais diferenciadas foi também correlacionado com maior número de células contendo altos níveis de granzima B, considerado um marcador para linfócitos citotóxicos, sendo também encontrado em maior número nas transferências de células do sangue periférico. Entretanto, no pós-transplante, observou-se que somente os receptores de transplante autólogo de células tronco mobilizadas para o sangue periférico, e não os das outras modalidades de transplante, exibiam números elevados de células T CD8+ de memória-efetora e efetora. Ao mesmo tempo, estes receptores apresentaram menos freqüentemente episódios de reativação pelo CMV, e mais freqüentemente produziram IFN-gama em resposta ao CMV. Portanto, a transferência de células do sangue periférico, desde que em ambiente autólogo, está associada não só com a transferência de células TCD8+ com um fenótipo mais maduro, mas também com uma persistência mais prolongada das mesmas, podendo proporcionar uma resposta imunológica antiviral mais rápida e eficiente, como esperado para as células de memória versus naïve. / Cytomegalovirus (CMV) is a serious threat to the recipients of bone marrow transplantation. Reactivation is associated with defective CD8+ T cell-mediated immunity. We aimed to correlate the different subsets of CD8+ T cells with the patients\' immune reconstitution, specifically anti CMV immunity, by analyzing the CD8+ T cell subsets infused in the different types of bone marrow transplantation. Recipients of allogeneic transplant of peripheral blood stem cells (n=16) or bone marrow (n=28) and recipients of autologous transplant of peripheral blood stem cells (n=22) were evaluated. We show that infusions of stem cells derived from donor\'s peripheral blood, either allogeneic or autologous, are proportionally enriched for the memory-effector and effector phenotypes, compared to the infusions of stem cells of bone marrow origin. This increased number of more differentiated subsets of CD8+ T cells was also correlated with an increased number of cells containing high levels of granzyme B, which is another reliable marker of cytotoxic lymphocyte, and which was also more evident in autologous recipients. However, post-transplant, we observed that only the recipients of autologous peripheral blood cells, and not the recipients of the other transplant modalities, exhibited very high numbers of memory-effector and effector TCD8+ cells. At the same time, they less frequently presented CMV reactivation, and more frequently produced IFN-gama in response to CMV antigens. Thus, transfer of stem cells from peripheral blood, provided in an autologous setting, is associated with transfer and prolonged survival of CD8+ T cells with a more mature phenotype, which may provide a more rapid and efficient anti-viral immune response, as expected for memory versus naïve cells.
|
838 |
Identification en thérapie cellulaire des patrons d’expression transcriptomique de cellules souches utilisées pour traiter la défaillance cardiaque afin d’en améliorer le potentiel thérapeutiqueSauvé, Jean-Alexandre 12 1900 (has links)
La cardiopathie ischémique incluant l’insuffisance cardiaque est la deuxième cause de mortalité annuelle au Canada. Bien que de nombreuses stratégies préventives et des thérapies pharmacologiques retardent la progression de la maladie, il n’existe aucune solution qui module directement aux les remaniements pathologiques et la perte de cardiomyocytes. Au cours des 25 dernières années, de multiples progrès dans les domaines de la médecine régénérative et de la thérapie cellulaire ont annoncé des résultats prometteurs, mais les résultats d’études cliniques contemporaines demeurent plutôt mitigés. COMPARE-AMI, une étude randomisée-contrôlée de phase II, a évalué l’effet d’injections intracoronariennes de cellules souches hématopoïétiques CD133+ chez des patients souffrant d’infarctus aigu. IMPACT-CABG, une ÉRC de phase II a également évalué l’effet d’injections intramyocardiques de cellules CD133+ chez les patients souffrant de cardiomyopathie ischémique chronique nécessitant une revascularisation chirurgicale. Nous avons émis l’hypothèse que les cellules CD133+ utilisées dans des études cliniques de cardiomyopathies ischémiques aiguës et chroniques des patients répondant à la thérapie cellulaire exhibent des signatures transcriptomiques communes responsables de leur effet thérapeutique. En classant les patients en tant que répondants et non-répondants selon leur fonction cardiaque, nous avons évalué, a posteriori, ces patrons d’expression. Les cellules CD133+ autologues de patients jugés répondants expriment des signatures qui sont hautement conservées entre elles (incluant l’angiogénèse, la régulation de la réponse au stress et la survie cellulaire) et uniques d’un modèle à l’autre et qui pourraient, en partie, exprimer les issus cliniques des patients. Afin de maximiser les effets de la thérapie cellulaire aux cellules souches, nous avons par la suite tenté de reproduire ces phénotypes par stimulation pharmacologique avec des inhibiteurs d’HSP90 pour leurs effets qui semblent reproduire ces signatures. Ainsi, nous avons démontré qu’une stimulation de cellules souches mésenchymateuses humaines (CSMh) au Célastrol (inhibiteur HSP90) pouvait répliquer certains de ces phénotypes. Notamment, des CSMh conditionnées activent des voies de signalisation de type ‘RISK’ et augmentent leur sécrétion de protéines en lien avec la réponse au stress ainsi que d’exosomes contenant des molécules impliquées dans la communication intercellulaire sans être liées à un changement de type cellulaire. De plus, les CSMh traitées semblent améliorer la guérison de plaie par activité paracrine et sont plus résistante à la sénescence oxydative. Ces résultats encourageants nous permettent d’envisager des stratégies plus poussées de pré-conditionnement cellulaire ex vivo de cellules CD133+ avant leur implantation. À terme, cela pourrait mener à une optimisation de la thérapie cellulaire afin d’en maximiser les bénéfices cliniques et d’en exploiter leur plein potentiel. / Ischemic cardiomyopathy and heart failure are the second annual cause of mortality in Canada.
Despite rigorous prevention strategies and drug regimens preventing progression, no therapeutic
modality can currently reverse the pathologic modifications of the disease. In the last quarter century,
numerous advances in the field of regenerative medicine and cell therapy have demonstrated promising
effects. COMPARE-AMI, a phase II randomized controlled trial (RCT), evaluated the effect of intracoronary
injection of CD133+ cells in acute myocardial infarction following percutaneous intervention. IMPACTCABG,
also a phase II RCT, evaluated the effect of intramyocardial injection of CD133+ hematopoietic stem
cells in chronic ischemic cardiomyopathy at the time of surgical revascularization. That being said, we
believe that the CD133+ cells used in therapy have shared transcriptomic signatures that are responsible
for their clinical effects. By classifying patients into responders and non-responders according to an
improvement in ejection fraction, we evaluated, a posteriori, those expression patterns. Autologous
CD133+ cells of patients classified as responders expressed highly conserved transcriptomic signatures
that could be responsible for the clinical outcomes of patients. Notably, these signatures were related to
cardioprotective mechanisms including angiogenesis, stress response regulation and cell survival. In order
to harness the full potential of stem cell therapy, we attempted to reproduce the identified phenotypes
by pharmacological intervention with HSP90 inhibitors which are known to mimic some of these effets.
Conditioned human mesenchymal stem cells (hMSC) activated ‘RISK’-type signaling pathways and
augmented exosome and protein secretion relating to the response to cellular stress; this activation was
unrelated to a switch of cell type. Furthermore, treated hMSC seemed to favour improved wound healing
by paracrine activity and were more resistant to oxidative senescence. These encouraging results allow
us to develop novel, more advance, strategies of ex vivo cell preconditioning before implantation,
including of CD133+ cells. Ultimately, we hope that optimisation of cells through this mechanism and
others will allow us to unleash the full potential of stem cell therapy.
|
839 |
A contribution to the selection of suitable cells, scaffold and biomechanical environment for ligament tissue engineering / Une contribution à la sélection de cellules adaptés, biomatériaux et d’environments biomécaniques appropriés pour l’ingéniere tissulaire ligamentaireLiu, Xing 01 July 2019 (has links)
L'ingénierie tissulaire du ligament constitue une approche prometteuse pour réparer ou remplacer un ligament endommagé. Les trois piliers essentiels de l'ingénierie tissulaire ligamentaire sont la matrice de support (aussi appelée scaffold), la source cellulaire, ainsi que l'apport de stimulations biomécaniques/biochimiques : ces trois piliers ont été partiellement étudiés par le passé dans le but de s’orienter vers une régénération ligamentaire. Dans la présente étude, le polymère synthétique poly (L-lactide-co-ε-caprolactone) (PLCL) et la soie ont été proposés et comparés comme de potentiels candidats pour la constitution d’une matrice de support. Une série de matrices tressées multicouches à base de PLCL et de soie, ainsi qu'un nouveau composite soie/PLCL ont été développés et comparés. Les caractérisations physico-chimiques et biologiques ont démontré que le PLCL et la soie constituent des candidats pertinents, tant sur les plans mécaniques que biologiques, pour la constitution d’une matrice de support. De plus, nous avons montré que le composite soie/PLCL offrait des propriétés mécaniques et une biocompatibilité accrue par rapport aux autres matrice testées, et constituait probablement le candidat le plus approprié pour l'ingénierie tissulaire du ligament. Les cellules souches mésenchymateuses (CSM) de la gelée de Wharton (WJ-MSCs) ainsi que les cellules souches mésenchymateuses de la moelle osseuse (BM-MSCs) ont été évaluées et comparées en tant que sources cellulaires potentielles pour la régénération ligamentaire. Les caractéristiques biologiques de ces cellules incluent l’adhésion cellulaire, la prolifération, la migration et la synthèse de matrice extracellulaire. Ces deux types de cellules ont montré une bonne biocompatibilité dans leurs interactions avec les matrices de support en PLCL et en soie. Aucune différence significative n'a été observée entre les WJ-MSCs et les BM-MSCs. Enfin, l'effet de la stimulation biomécanique sur la différentiation des CSM en tissu ligamentaire a été évalué par le biais d’un bioréacteur de traction-torsion. Bien que peu de cellules aient été détectées la matrice après 7 jours de stimulation, des CSM de forme allongée le long des fibres ont été détectées, ce qui permet de penser qu'il est possible de promouvoir la différenciation des biosubstituts matrice-cellules grâce à la stimulation mécanique en bioréacteur. En conclusion, cette étude démontre le potentiel prometteur de l’association de cellules souches mésenchymateuses issues de la gelée de Wharton ou de la moelle osseuse avec une matrice de support composite soie/PLCL pour la régénération ligamentaire dans le futur. / Ligament tissue engineering offers a potential approach to recover or replace injured ligament. The three essential elements that have been investigated towards ligament regeneration consist in a suitable scaffold, an adapted cell source, and the supply of biomechanical/biochemical stimulations. In the current study, synthetic polymer poly (L-lactide-co-ε-caprolactone) (PLCL) and silk have been evaluated as suitable candidates to constitute an adapted scaffold. A series of multilayer braided scaffolds based on PLCL and silk, as well as an original silk/PLCL composite scaffold, have been developed and compared. The conducted physicochemical and biological characterizations have demonstrated that both PLCL and silk constitute adapted candidate material to form ligament scaffolds from the mechanical and biological points of view. Moreover, it has been observed that silk/PLCL composite scaffold resulted in adequate mechanical properties and biocompatibility, and therefore could constitute suitable candidate scaffolds for ligament tissue engineering. Both Wharton’s Jelly mesenchymal stem cells (WJ-MSCs) and Bone marrow mesenchymal stem cells (BM-MSCs) have been evaluated to be cell source for ligament regeneration. MSCs behaviors including cell attachment, proliferation, migration and extracellular matrix synthesis have been investigated. In the present study, both MSCS showed a good biocompatibility to interact with PLCL and silk scaffolds. No significant differences have been detected between WJ-MSCs and BM-MSCs. Finally, the effect of biomechanical stimulation on MSCs differentiation towards ligament tissue has been carried out with a tension-torsion bioreactor. Although few cells were detected on scaffold after 7 days of stimulation, MSCs were observed to exhibit an elongated shape along the longitudinal direction of fibers, which may indicate that an adapted mechanical stimulation could promote MSC-scaffold constructs differentiation towards ligamentous tissue. As a conclusion, this study demonstrates the potential of WJ-MSCs and BM-MSCs combined with a new silk/PLCL composite scaffold towards ligament regeneration.
|
840 |
Gene expression of tendon markers in mesenchymal stromal cells derived from different sourcesBurk, Janina, Gittel, Claudia, Heller, Sandra, Pfeiffer, Bastian, Paebst, Felicitas, Ahrberg, Annette B., Brehm, Walter January 2014 (has links)
Background: Multipotent mesenchymal stromal cells (MSC) can be recovered from a variety of tissues in the body. Yet, their functional properties were shown to vary depending on tissue origin. While MSC have emerged as a favoured cell type for tendon regenerative therapies, very little is known about the influence of the MSC source on
their properties relevant to tendon regeneration. The aim of this study was to assess and compare the expression of tendon extracellular matrix proteins and tendon differentiation markers in MSC derived from different sources as well as in native tendon tissue. MSC isolated from equine bone marrow, adipose tissue, umbilical cord tissue, umbilical cord blood and tendon tissue were characterized and then subjected to mRNA analysis by real-time polymerase chain reaction. Results: MSC derived from adipose tissue displayed the highest expression of collagen 1A2, collagen 3A1 and decorin compared to MSC from all other sources and native tendon tissue (p < 0.01). Tenascin-C and scleraxis
expressions were highest in MSC derived from cord blood compared to MSC derived from other sources, though both tenascin-C and scleraxis were expressed at significantly lower levels in all MSC compared to native tendon tissue (p < 0.01). Conclusions: These findings demonstrate that the MSC source impacts the cell properties relevant to tendon regeneration. Adipose derived MSC might be superior regarding their potential to positively influence tendon matrix reorganization.
|
Page generated in 0.0325 seconds